2026
Aartsma-Rus A et Al. « TREAT-NMD advisory committee for therapeutics: Preclinical and clinical learnings from 15 years of TACT. » J Neuromuscul Dis: 22143602261438534
Beard, N et Al.
« Impact of downstream purification process and AAV serotype on protein-impurity clearance. »
Mol Ther Adv 34(2): 201752.
Boespflug-Tanguy, O
« Death following high-dose AAV9 gene therapy in a patient with advanced SMA-PME. »
Mol Ther.
Bon E et Al.
« Flunarizine changes microRNA expression in cell cultures and in a mouse model of spinal muscular atrophy »
Sci Rep 16(1)
Bruge C et Al.
« DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation »
JCI Insight 11(6).
